BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF
3196 results:

  • 1. Neoadjuvant immune checkpoint blockade enhances local and systemic tumor immunity in head and neck cancer.
    Zhao Y; Wucherpfennig KW
    Curr Opin Oncol; 2024 May; 36(3):136-142. PubMed ID: 38573202
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Therapeutic effects of compression therapy on taxane-induced peripheral neuropathy incidence, negative emotions, and sleep disorders in patients with breast cancer.
    Dongxue G; Ran L; Fangfei Z; Zirui Z; Lizhi Z
    Support Care Cancer; 2024 Apr; 32(4):260. PubMed ID: 38561474
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Cytotoxic effect of Rotheca serrata on cancer cell lines MCF-7 and neuroblastoma SH-SY5Y.
    Gadade JP; Patil SA
    J Cancer Res Ther; 2024 Jan; 20(1):181-188. PubMed ID: 38554318
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Purification and biochemical characterization of the G4 resolvase and DNA helicase fancj.
    Kulikowicz T; Sommers JA; Fuchs KF; Wu Y; Brosh RM
    Methods Enzymol; 2024; 695():1-27. PubMed ID: 38521581
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A metabolomics approach reveals metabolic disturbance of human cholangiocarcinoma cells after parthenolide treatment.
    He Y; Yu Q; Ma X; Lv D; Wang H; Qiu W; Chen XF; Jiao Y; Liu Y
    J Ethnopharmacol; 2024 Jun; 328():118075. PubMed ID: 38513779
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Zirconium-containing nanoscale coordination polymers for positron emission tomography and fluorescence-guided cargo delivery to triple-negative breast tumors.
    Li YP; Pan ZW; Jiang YJ; Peng YY; Cai T; Hong H; Wang XF
    Acta Biomater; 2024 Apr; 179():313-324. PubMed ID: 38490483
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Towards clinical adherence monitoring of oral endocrine breast cancer therapies by LC-HRMS-method development, validation, comparison of four sample matrices, and proof of concept.
    Jacobs CM; Radosa JC; Wagmann L; Zimmermann JSM; Kaya AC; Aygün A; Edel T; Stotz L; Ismaeil M; Solomayer EF; Meyer MR
    Anal Bioanal Chem; 2024 May; 416(12):2969-2981. PubMed ID: 38488952
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Epiberberine inhibits bone metastatic breast cancer-induced osteolysis.
    Wei C; Shi M; Wang Z; Lan W; Feng N; Zhang F; Liu J; Lang JY; Lin W; Ma W
    J Ethnopharmacol; 2024 Jun; 327():118039. PubMed ID: 38479545
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Rujifang inhibits triple-negative breast cancer growth via the PI3K/AKT pathway.
    Jia W; Lin X; Chen X; Li H; Zhang X; Zhang Y; Chen Y; Wang B; Chen X; Chen J; Tian H
    J Ethnopharmacol; 2024 Jun; 327():118011. PubMed ID: 38467320
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Printing of 3D biomimetic structures for the study of bone metastasis: A review.
    Khanmohammadi M; Volpi M; Walejewska E; Olszewska A; Swieszkowski W
    Acta Biomater; 2024 Apr; 178():24-40. PubMed ID: 38458512
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Altered hormone expression induced genetic changes leads to breast cancer.
    Thakur A; Rana N; Kumar R
    Curr Opin Oncol; 2024 Mar; 36(2):115-122. PubMed ID: 38441060
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair genes.
    Olmos D; Lorente D; Alameda D; Cattrini C; Romero-Laorden N; Lozano R; Lopez-Casas PP; Jambrina A; Capone C; Vanden Broecke AM; Trevisan M; Van Sanden S; Jürgens A; Herrera-Imbroda B; Castro E
    Ann Oncol; 2024 May; 35(5):458-472. PubMed ID: 38417742
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Addressing Residual Disease in HER2-Positive and Triple-Negative breast cancer: What Is Next?
    Schlam I; Dower J; Lynce F
    Curr Oncol Rep; 2024 Apr; 26(4):336-345. PubMed ID: 38393609
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Increased matrix stiffness enhances pro-tumorigenic traits in a physiologically relevant breast tissue- monocyte 3D model.
    Abrahamsson A; Boroojeni FR; Naeimipour S; Reustle N; Selegård R; Aili D; Dabrosin C
    Acta Biomater; 2024 Apr; 178():160-169. PubMed ID: 38382828
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Integrating serum pharmacochemistry and network pharmacology to explore the molecular mechanisms of Acanthopanax senticosus (Rupr. & Maxim.) Harms on attenuating doxorubicin-induced myocardial injury.
    Zhang X; Zhang Q; Yu M; Zhang Y; He T; Qiu Z; Qiu Y; Wang W
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117349. PubMed ID: 38380572
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Effect of Osteoporosis Treatments on Osteoarthritis Progression in Postmenopausal Women: A Review of the Literature.
    Ho WC; Chang CC; Wu WT; Lee RP; Yao TK; Peng CH; Yeh KT
    Curr Rheumatol Rep; 2024 May; 26(5):188-195. PubMed ID: 38372871
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The Herbal Combination Shu Gan Jie Yu Regulates the SNCG/ER-a/AKT-ERK Pathway in DMBA-Induced breast cancer and breast cancer Cell Lines Based on RNA-Seq and IPA Analysis.
    Zhao Y; Zhao L; Wang T; Liu Z; Tang S; Huang H; Wu L; Sun Y
    Integr Cancer Ther; 2024; 23():15347354241233258. PubMed ID: 38369762
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The FALD-V: A predictive formula for preoperative volume assessment of adipose tissue transplantation in FALD flap.
    Longo B; D'Orsi G; Farcomeni A; Pistoia A; Giacalone M; Gagliano E; Vannucchi L; Vanni G; Buonomo CO; Cervelli V
    J Plast Reconstr Aesthet Surg; 2024 Mar; 90():25-34. PubMed ID: 38340688
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Cost-Effectiveness of Gene-Specific Prevention Strategies for Ovarian and breast cancer.
    Wei X; Sun L; Slade E; Fierheller CT; Oxley S; Kalra A; Sia J; Sideris M; McCluggage WG; Bromham N; Dworzynski K; Rosenthal AN; Brentnall A; Duffy S; Evans DG; Yang L; Legood R; Manchanda R
    JAMA Netw Open; 2024 Feb; 7(2):e2355324. PubMed ID: 38334999
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. EXPRESSION PROFILE OF miR-145, -182, -21, -27a, -29b, and -34a IN breast cancer PATIENTS OF YOUNG AGE.
    Chekhun V; Borikun T; Mushii O; Zadvornyi T; Martyniuk О; Kashuba E; Bazas V; Hrybach S; Krotevych M; Lyalkin S; Lukianova N
    Exp Oncol; 2024 Feb; 45(4):421-431. PubMed ID: 38328848
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 160.